YD Bio与EG Biomed签署合并谅解备忘录,推进DNA甲基化驱动AI平台在癌症诊断与药物开发领域的应用

美股速递
Jan 06

YD Bio Ltd已与EG Biomed达成合并谅解备忘录,双方将整合资源,共同推进基于DNA甲基化技术的人工智能平台在癌症精准诊断及创新药物研发领域的深度应用。此次合作旨在加速癌症早期筛查技术的商业化进程,并为靶向治疗方案的开发提供数据支持。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10